• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cdk5 通过调节大脑区域特异性底物对亨廷顿病的学习和记忆缺陷有贡献。

Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.

机构信息

Departament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Barcelona, Spain.

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

出版信息

Mol Neurobiol. 2018 Aug;55(8):6250-6268. doi: 10.1007/s12035-017-0828-4. Epub 2017 Dec 29.

DOI:10.1007/s12035-017-0828-4
PMID:29288339
Abstract

Cognitive deficits are a major hallmark of Huntington's disease (HD) with a great impact on the quality of patient's life. Gaining a better understanding of the molecular mechanisms underlying learning and memory impairments in HD is, therefore, of critical importance. Cdk5 is a proline-directed Ser/Thr kinase involved in the regulation of synaptic plasticity and memory processes that has been associated with several neurodegenerative disorders. In this study, we aim to investigate the role of Cdk5 in learning and memory impairments in HD using a novel animal model that expresses mutant huntingtin (mHtt) and has genetically reduced Cdk5 levels. Genetic reduction of Cdk5 in mHtt knock-in mice attenuated both corticostriatal learning deficits as well as hippocampal-dependent memory decline. Moreover, the molecular mechanisms by which Cdk5 counteracts the mHtt-induced learning and memory impairments appeared to be differentially regulated in a brain region-specific manner. While the corticostriatal learning deficits are attenuated through compensatory regulation of NR2B surface levels, the rescue of hippocampal-dependent memory was likely due to restoration of hippocampal dendritic spine density along with an increase in Rac1 activity. This work identifies Cdk5 as a critical contributor to mHtt-induced learning and memory deficits. Furthermore, we show that the Cdk5 downstream targets involved in memory and learning decline differ depending on the brain region analyzed suggesting that distinct Cdk5 effectors could be involved in cognitive impairments in HD.

摘要

认知缺陷是亨廷顿病(HD)的主要标志,对患者的生活质量有重大影响。因此,更好地了解 HD 中学习和记忆障碍的分子机制至关重要。Cdk5 是一种脯氨酸导向的 Ser/Thr 激酶,参与调节突触可塑性和记忆过程,与几种神经退行性疾病有关。在这项研究中,我们旨在使用一种新型动物模型来研究 Cdk5 在 HD 学习和记忆障碍中的作用,该模型表达突变型亨廷顿蛋白(mHtt)并且基因水平降低了 Cdk5 水平。在 mHtt 敲入小鼠中降低 Cdk5 的基因表达,减轻了皮质纹状体学习缺陷以及海马依赖性记忆下降。此外,Cdk5 拮抗 mHtt 诱导的学习和记忆障碍的分子机制似乎以脑区特异性的方式受到差异调节。虽然通过 NR2B 表面水平的代偿性调节减轻了皮质纹状体学习缺陷,但海马依赖性记忆的恢复可能是由于海马树突棘密度的增加以及 Rac1 活性的增加所致。这项工作确定 Cdk5 是 mHtt 诱导的学习和记忆障碍的关键贡献者。此外,我们表明,参与记忆和学习下降的 Cdk5 下游靶标因分析的脑区而异,这表明不同的 Cdk5 效应物可能参与了 HD 中的认知障碍。

相似文献

1
Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.Cdk5 通过调节大脑区域特异性底物对亨廷顿病的学习和记忆缺陷有贡献。
Mol Neurobiol. 2018 Aug;55(8):6250-6268. doi: 10.1007/s12035-017-0828-4. Epub 2017 Dec 29.
2
Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens.周期蛋白依赖性激酶 5 功能障碍通过改变伏隔核中的 DARPP-32 磷酸化状态导致亨廷顿病的抑郁样行为。
Biol Psychiatry. 2019 Aug 1;86(3):196-207. doi: 10.1016/j.biopsych.2019.03.001. Epub 2019 Mar 13.
3
Recent advances in understanding the roles of Cdk5 in synaptic plasticity.在理解Cdk5在突触可塑性中的作用方面的最新进展。
Biochim Biophys Acta. 2009 Aug;1792(8):741-5. doi: 10.1016/j.bbadis.2009.05.001. Epub 2009 May 13.
4
Memory enhancement by targeting Cdk5 regulation of NR2B.靶向 Cdk5 调节 NR2B 增强记忆。
Neuron. 2014 Mar 5;81(5):1070-1083. doi: 10.1016/j.neuron.2014.01.022.
5
Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of Huntington's disease.在亨廷顿舞蹈病小鼠模型中,改变的感觉体验会加剧稳定树突棘和突触的丧失。
J Neurosci. 2015 Jan 7;35(1):287-98. doi: 10.1523/JNEUROSCI.0244-14.2015.
6
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.垂体腺苷酸环化酶激活肽(PACAP)增强亨廷顿病中海马突触可塑性和改善记忆功能。
Mol Neurobiol. 2018 Nov;55(11):8263-8277. doi: 10.1007/s12035-018-0972-5. Epub 2018 Mar 10.
7
Formation of hippocampal mHTT aggregates leads to impaired spatial memory, hippocampal activation and adult neurogenesis.海马体突变亨廷顿蛋白聚集体的形成会导致空间记忆受损、海马体激活异常及成年神经发生障碍。
Neurobiol Dis. 2017 Jun;102:105-112. doi: 10.1016/j.nbd.2017.03.005. Epub 2017 Mar 9.
8
Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease.突触 RTP801 导致亨廷顿病运动学习功能障碍。
Cell Death Dis. 2020 Jul 30;11(7):569. doi: 10.1038/s41419-020-02775-5.
9
Prostaglandin E2 EP2 activation reduces memory decline in R6/1 mouse model of Huntington's disease by the induction of BDNF-dependent synaptic plasticity.前列腺素 E2 EP2 激活通过诱导 BDNF 依赖性突触可塑性减少亨廷顿病 R6/1 小鼠模型的记忆下降。
Neurobiol Dis. 2016 Nov;95:22-34. doi: 10.1016/j.nbd.2015.09.001. Epub 2015 Sep 11.
10
Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.在亨廷顿病模型的早期阶段,腺苷 A2A 受体的失活可逆转工作记忆缺陷。
Neurobiol Dis. 2015 Jul;79:70-80. doi: 10.1016/j.nbd.2015.03.030. Epub 2015 Apr 16.

引用本文的文献

1
Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models.恢复海马体γ-氨基丁酸能神经元中CB1受体功能可挽救亨廷顿舞蹈症模型中的记忆缺陷。
Transl Neurodegener. 2025 Aug 25;14(1):44. doi: 10.1186/s40035-025-00500-w.
2
Neuronal CDK5RAP3 deficiency leads to encephalo-dysplasia via upregulation of N-glycosylases and glycogen deposition.神经元CDK5RAP3缺乏通过上调N-糖基化酶和糖原沉积导致脑发育异常。
Cell Death Discov. 2025 Apr 6;11(1):146. doi: 10.1038/s41420-025-02414-y.
3
Roscovitine, a CDK Inhibitor, Reduced Neuronal Toxicity of mHTT by Targeting HTT Phosphorylation at S1181 and S1201 In Vitro.

本文引用的文献

1
Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF.亨廷顿舞蹈病中的认知功能障碍:超越脑源性神经营养因子的机制与治疗策略
Brain Pathol. 2016 Nov;26(6):752-771. doi: 10.1111/bpa.12432.
2
CDK5 downregulation enhances synaptic plasticity.细胞周期蛋白依赖性激酶5(CDK5)的下调增强了突触可塑性。
Cell Mol Life Sci. 2017 Jan;74(1):153-172. doi: 10.1007/s00018-016-2333-8. Epub 2016 Aug 9.
3
Striatal synaptic dysfunction and altered calcium regulation in Huntington disease.亨廷顿病中的纹状体突触功能障碍与钙调节异常
罗克洛文,一种 CDK 抑制剂,通过靶向 HTT 在 S1181 和 S1201 上的磷酸化,减少了 mHTT 的神经元毒性。
Int J Mol Sci. 2024 Nov 16;25(22):12315. doi: 10.3390/ijms252212315.
4
Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease.细胞周期蛋白依赖性激酶 5(CDK5)抑制剂在帕金森病中的应用。
J Cell Mol Med. 2024 Jun;28(11):e18412. doi: 10.1111/jcmm.18412.
5
Inhibition of hippocampal cyclin-dependent kinase 5 activity ameliorates learning and memory dysfunction in a mouse model of bronchopulmonary dysplasia.抑制海马细胞周期蛋白依赖性激酶 5 活性可改善支气管肺发育不良小鼠模型的学习记忆功能障碍。
CNS Neurosci Ther. 2023 Aug;29(8):2339-2354. doi: 10.1111/cns.14185. Epub 2023 Mar 25.
6
Cdk5 mediates rotational force-induced brain injury.Cdk5 介导旋转力诱导的脑损伤。
Sci Rep. 2023 Feb 28;13(1):3394. doi: 10.1038/s41598-023-29322-4.
7
Phosphoproteomic dysregulation in Huntington's disease mice is rescued by environmental enrichment.环境富集可挽救亨廷顿舞蹈病小鼠的磷酸化蛋白质组失调。
Brain Commun. 2022 Nov 21;4(6):fcac305. doi: 10.1093/braincomms/fcac305. eCollection 2022.
8
Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders.聚焦细胞周期蛋白依赖性激酶5:神经系统疾病的潜在靶点。
Front Mol Neurosci. 2022 Nov 10;15:1030639. doi: 10.3389/fnmol.2022.1030639. eCollection 2022.
9
Protein Kinase CK2 and Its Potential Role as a Therapeutic Target in Huntington's Disease.蛋白激酶CK2及其作为亨廷顿舞蹈病治疗靶点的潜在作用。
Biomedicines. 2022 Aug 15;10(8):1979. doi: 10.3390/biomedicines10081979.
10
The role of Cdk5 in neurological disorders.细胞周期蛋白依赖性激酶5在神经疾病中的作用。
Front Cell Neurosci. 2022 Jul 28;16:951202. doi: 10.3389/fncel.2022.951202. eCollection 2022.
Biochem Biophys Res Commun. 2017 Feb 19;483(4):1051-1062. doi: 10.1016/j.bbrc.2016.07.058. Epub 2016 Jul 14.
4
Dendritic Spine Pathology in Neurodegenerative Diseases.神经退行性疾病中的树突棘病理。
Annu Rev Pathol. 2016 May 23;11:221-50. doi: 10.1146/annurev-pathol-012615-044216. Epub 2016 Feb 22.
5
A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease.卡利林-7在亨廷顿舞蹈病皮质纹状体突触功能障碍中的作用。
Hum Mol Genet. 2015 Dec 20;24(25):7265-85. doi: 10.1093/hmg/ddv426. Epub 2015 Oct 12.
6
Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson's disease.源自细胞周期蛋白依赖性激酶5激活剂P35的肽TFP5/TP5在帕金森病的MPTP模型中具有神经保护作用。
Mol Biol Cell. 2015 Dec 1;26(24):4478-91. doi: 10.1091/mbc.E15-06-0415. Epub 2015 Sep 23.
7
CDK5 knockdown in astrocytes provide neuroprotection as a trophic source via Rac1.星形胶质细胞中的细胞周期蛋白依赖性激酶5(CDK5)基因敲低通过Rac1作为营养源提供神经保护作用。
Mol Cell Neurosci. 2015 Sep;68:151-66. doi: 10.1016/j.mcn.2015.07.001. Epub 2015 Jul 6.
8
Cdk5-mediated mitochondrial fission: A key player in dopaminergic toxicity in Huntington's disease.细胞周期蛋白依赖性激酶5介导的线粒体裂变:亨廷顿舞蹈病中多巴胺能毒性的关键因素
Biochim Biophys Acta. 2015 Oct;1852(10 Pt A):2145-60. doi: 10.1016/j.bbadis.2015.06.025. Epub 2015 Jul 2.
9
CDK5 knockdown prevents hippocampal degeneration and cognitive dysfunction produced by cerebral ischemia.CDK5基因敲低可预防脑缺血所致的海马退变和认知功能障碍。
J Cereb Blood Flow Metab. 2015 Dec;35(12):1937-49. doi: 10.1038/jcbfm.2015.150. Epub 2015 Jun 24.
10
A novel phosphorylation site of N-methyl-D-aspartate receptor GluN2B at S1284 is regulated by Cdk5 in neuronal ischemia.N-甲基-D-天冬氨酸受体GluN2B在S1284处的一个新磷酸化位点在神经元缺血中受细胞周期蛋白依赖性激酶5(Cdk5)调控。
Exp Neurol. 2015 Sep;271:251-8. doi: 10.1016/j.expneurol.2015.06.016. Epub 2015 Jun 17.